Cambridge Innovation Capital

Cambridge Innovation Capital is a venture capital firm focusing on high-growth technology and life sciences companies, providing investment capital and operational support to foster innovation and growth across various sectors. Founded in 2013, Cambridge Innovation Capital is based in Cambridge, UK, and specializes in investing in technology and life sciences sectors. The firm has been involved in 2 deals, with their most recent funding round occurring on September 1, 2016, when they raised GBP 75 million from notable investors including Oman Investment Fund and Woodford Investment Management. The company is not known to have undergone significant pivots or changes in strategy since its inception.

The current valuation of the company stands at GBP 157. 35 million post-money. Cambridge Innovation Capital focuses on providing exceptional funding and support to high-growth technology and life sciences companies. Their core offerings include strategic investment capital, operational expertise, and access to a robust network of industry contacts that foster innovation and growth.

The end use cases for their investments often revolve around solving critical challenges within sectors such as health technology, artificial intelligence, and advanced manufacturing, ultimately aiming to bring transformative solutions to market. Their client base consists of emerging companies at various stages of development, particularly those targeting breakthrough advancements in their respective fields. Cambridge Innovation Capital serves an international market, with a focus on leading technology hubs across Europe and North America, ensuring that they connect with companies poised for significant impact. The revenue model primarily relies on equity investment transactions in their portfolio companies, alongside potential returns from successful exits, such as IPOs or acquisitions.

Transactions usually occur through direct investments, where the firm partners with early and growth-stage businesses to provide necessary capital in exchange for equity stakes. This partnership-oriented approach aligns the interests of both the firm and its clients for mutual growth, and they may also engage in co-investment opportunities alongside other investors. Cambridge Innovation Capital plans to enhance its portfolio through further investments in innovative companies. The GBP 75 million raised in their latest funding round will be utilized to support the scaling of their portfolio firms and potentially facilitate the launch of new products aimed at addressing critical market needs.

The firm is also considering expansion into emerging markets across Asia and the Middle East by the end of 2025, targeting regions that are increasingly investing in technology and life sciences. This strategic move aims to leverage their existing network to connect with new clients in these promising markets.